Purchase of Alpha-pegunigalsidase AI

TEDAS your procurement assistant

Ask a question about this procurement

t

Subject of Procurement * Procurement title: Purchase of Alpha-pegunigalsidase. * Subject: Enzyme replacement therapy for Fabry disease with the active substance alpha-pegunigalsidase (medicinal products). * Technical requirements: * Medicinal products must have a marketing authorization from the State Agency of Medicines or the European Commission or possess an import/usage permit. * The packaging must feature an intact anti-tampering device and a unique identifier recognizable by the Estonian national database of medicinal product safety features…

 
To see full summary, please log in or register.

t

👋 Hello! I am TEDAS – your procurement assistant 💼✨

What would you like to know about this procurement?

Note: This is preliminary information. For accuracy, please review all procurement documents.
Ask your questions here...

309299_ESPD_v2.0_laiendatud.xml

309299_hankepass_taiendavate_selgitustega.pdf

309299_hindamiskriteeriumid.pdf

309299_vastavustingimused.pdf

309299.zip

Faili HD lisa 1 Tehniline kirjeldus ja hinnapakkumuse vorm koopia.xlsx

Hankedokument.pdf

HD lisa 2 Raamlepingu projekt.pdf

HD lisa 3 Pakkumusvormid.docx

HD lisa 3 vorm I - Avaldus.docx

Ready to get started?

Subscribe and enjoy all the benefits every day!